Spiriva (Tiotropium bromide) for COPD | MyCOPDTeam

Connect with others who understand.

sign up Log in
About MyCOPDTeam
Powered By

Spiriva is a prescription drug approved by the Food and Drug Administration (FDA) for long-term, once-daily maintenance treatment of bronchospasms in people with chronic obstructive pulmonary disease (COPD), and to reduce the risk of COPD exacerbations. Spiriva is also known by its drug name, Tiotropium bromide.

Spiriva is an anticholinergic drug and a long-acting bronchodilator, or drug that dilates the bronchi and bronchioles in the lungs, making it easier to breathe. Spiriva is believed to work by relaxing smooth muscles in the airways.

How do I take it?
Spiriva is taken once daily.

Spiriva comes in two forms. Spiriva HandiHaler comes in the form of powder capsules delivered with the special HandiHaler inhaler. Spiriva Respimat comes in the form of an inhalation spray delivered with the special Respimat inhaler.

Side effects
The FDA-approved label for Spiriva lists common side effects including cold symptoms, cough, dry mouth, and sinusitis.

Rare but serious side effects listed for Spiriva can include worsening of glaucoma or urinary retention, hypersensitivity reactions, and paradoxical bronchospasm (bronchospasm caused by medication).

For more details about this treatment, visit:

Spiriva – Boehringer Ingelheim

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in